These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
719 related articles for article (PubMed ID: 9886807)
21. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling. Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778 [TBL] [Abstract][Full Text] [Related]
22. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways. Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504 [TBL] [Abstract][Full Text] [Related]
23. Functional importance of Shc tyrosine 317 on insulin signaling in Rat1 fibroblasts expressing insulin receptors. Ishihara H; Sasaoka T; Ishiki M; Takata Y; Imamura T; Usui I; Langlois WJ; Sawa T; Kobayashi M J Biol Chem; 1997 Apr; 272(14):9581-6. PubMed ID: 9083103 [TBL] [Abstract][Full Text] [Related]
24. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner. Zhang-Sun G; Yang C; Viallet J; Feng G; Bergeron JJ; Posner BI Endocrinology; 1996 Jul; 137(7):2649-58. PubMed ID: 8770882 [TBL] [Abstract][Full Text] [Related]
25. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells. Hennige AM; Lammers R; Arlt D; Höppner W; Strack V; Niederfellner G; Seif FJ; Häring HU; Kellerer M Mol Cell Endocrinol; 2000 Sep; 167(1-2):69-76. PubMed ID: 11000521 [TBL] [Abstract][Full Text] [Related]
26. Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase. Lecoq-Lafon C; Verdier F; Fichelson S; Chrétien S; Gisselbrecht S; Lacombe C; Mayeux P Blood; 1999 Apr; 93(8):2578-85. PubMed ID: 10194437 [TBL] [Abstract][Full Text] [Related]
27. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner. Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728 [TBL] [Abstract][Full Text] [Related]
28. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. Noguchi T; Matozaki T; Horita K; Fujioka Y; Kasuga M Mol Cell Biol; 1994 Oct; 14(10):6674-82. PubMed ID: 7935386 [TBL] [Abstract][Full Text] [Related]
29. Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/Akt pathways. Carvalho CR; Carvalheira JB; Lima MH; Zimmerman SF; Caperuto LC; Amanso A; Gasparetti AL; Meneghetti V; Zimmerman LF; Velloso LA; Saad MJ Endocrinology; 2003 Feb; 144(2):638-47. PubMed ID: 12538627 [TBL] [Abstract][Full Text] [Related]
30. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. Ram PA; Waxman DJ J Biol Chem; 1997 Jul; 272(28):17694-702. PubMed ID: 9211920 [TBL] [Abstract][Full Text] [Related]
31. Reciprocal feedback regulation of insulin receptor and insulin receptor substrate tyrosine phosphorylation by phosphoinositide 3-kinase in primary adipocytes. Hers I; Bell CJ; Poole AW; Jiang D; Denton RM; Schaefer E; Tavaré JM Biochem J; 2002 Dec; 368(Pt 3):875-84. PubMed ID: 12220227 [TBL] [Abstract][Full Text] [Related]
32. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts. Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010 [TBL] [Abstract][Full Text] [Related]
33. Insulin induces tyrosine phosphorylation of Shc and stimulates Shc/GRB2 association in insulin-sensitive tissues of the intact rat. Páez-Espinosa V; Carvalho CR; Alvarez-Rojas F; Janeri L; Velloso LA; Boschero AC; Saad MJ Endocrine; 1998 Apr; 8(2):193-200. PubMed ID: 9704577 [TBL] [Abstract][Full Text] [Related]
34. Negative signaling in B cells causes reduced Ras activity by reducing Shc-Grb2 interactions. Tridandapani S; Chacko GW; Van Brocklyn JR; Coggeshall KM J Immunol; 1997 Feb; 158(3):1125-32. PubMed ID: 9013951 [TBL] [Abstract][Full Text] [Related]
35. Effect of nutritional state on the formation of a complex involving insulin receptor IRS-1, the 52 kDa Src homology/collagen protein (Shc) isoform and phosphatidylinositol 3'-kinase activity. Dupont J; Derouet M; Simon J; Taouis M Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):293-300. PubMed ID: 9761726 [TBL] [Abstract][Full Text] [Related]
36. Early steps of insulin action in the skin of intact rats. Pelegrinelli FF; Thirone AC; Gasparetti AL; Araujo EP; Velloso LA; Saad MJ J Invest Dermatol; 2001 Oct; 117(4):971-6. PubMed ID: 11676840 [TBL] [Abstract][Full Text] [Related]
37. Src-family tyrosine kinases in activation of ERK-1 and p85/p110-phosphatidylinositol 3-kinase by G/CCKB receptors. Daulhac L; Kowalski-Chauvel A; Pradayrol L; Vaysse N; Seva C J Biol Chem; 1999 Jul; 274(29):20657-63. PubMed ID: 10400698 [TBL] [Abstract][Full Text] [Related]
38. SHPTP2 serves adapter protein linking between Janus kinase 2 and insulin receptor substrates. Maegawa H; Kashiwagi A; Fujita T; Ugi S; Hasegawa M; Obata T; Nishio Y; Kojima H; Hidaka H; Kikkawa R Biochem Biophys Res Commun; 1996 Nov; 228(1):122-7. PubMed ID: 8912646 [TBL] [Abstract][Full Text] [Related]
39. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors. Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701 [TBL] [Abstract][Full Text] [Related]
40. Different pathways of postreceptor desensitization following chronic insulin treatment and in cells overexpressing constitutively active insulin receptors. Inoue G; Cheatham B; Kahn CR J Biol Chem; 1996 Nov; 271(45):28206-11. PubMed ID: 8910437 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]